In present study, therefore, we separately investigate the expression levels of miRNA-200a and its potential target gene HGF in stromal fibroblasts and cancer cells from specimens of NSCLC, and evaluate the prognostic significance of these markers in patients with clinical stage I -IIIA NSCLC after curative resection. This evidence concerns the gene HGF and non-small cell lung carcinoma.